Amends TCA Title 4; Title 56 and Title 71.

Tennessee SB2499 requires managed care organizations and pharmacy benefits managers contracted with the bureau to reimburse claims for long-acting injectable drugs used for the treatment and prevention of HIV when administered in various healthcare settings, including pharmacies, physician's offices, clinics, ambulatory surgical treatment centers, or hospitals. This bill affects patients receiving HIV treatment, healthcare providers administering these medications, and the managed care organizations and pharmacy benefits managers involved in the reimbursement process. Key provisions include the stipulation for reimbursement across specified healthcare settings for these injectable drugs.